Smith Susan M, Wallace Emma, O'Dowd Tom, Fortin Martin
HRB Centre for Primary Care Research, Department of General Practice, RCSI Medical School, 123 St Stephens Green, Dublin 2, Ireland.
Cochrane Database Syst Rev. 2016 Mar 14;3(3):CD006560. doi: 10.1002/14651858.CD006560.pub3.
Many people with chronic disease have more than one chronic condition, which is referred to as multimorbidity. The term comorbidity is also used but this is now taken to mean that there is a defined index condition with other linked conditions, for example diabetes and cardiovascular disease. It is also used when there are combinations of defined conditions that commonly co-exist, for example diabetes and depression. While this is not a new phenomenon, there is greater recognition of its impact and the importance of improving outcomes for individuals affected. Research in the area to date has focused mainly on descriptive epidemiology and impact assessment. There has been limited exploration of the effectiveness of interventions to improve outcomes for people with multimorbidity.
To determine the effectiveness of health-service or patient-oriented interventions designed to improve outcomes in people with multimorbidity in primary care and community settings. Multimorbidity was defined as two or more chronic conditions in the same individual.
We searched MEDLINE, EMBASE, CINAHL and seven other databases to 28 September 2015. We also searched grey literature and consulted experts in the field for completed or ongoing studies.
Two review authors independently screened and selected studies for inclusion. We considered randomised controlled trials (RCTs), non-randomised clinical trials (NRCTs), controlled before-after studies (CBAs), and interrupted time series analyses (ITS) evaluating interventions to improve outcomes for people with multimorbidity in primary care and community settings. Multimorbidity was defined as two or more chronic conditions in the same individual. This includes studies where participants can have combinations of any condition or have combinations of pre-specified common conditions (comorbidity), for example, hypertension and cardiovascular disease. The comparison was usual care as delivered in that setting.
Two review authors independently extracted data from the included studies, evaluated study quality, and judged the certainty of the evidence using the GRADE approach. We conducted a meta-analysis of the results where possible and carried out a narrative synthesis for the remainder of the results. We present the results in a 'Summary of findings' table and tabular format to show effect sizes across all outcome types.
We identified 18 RCTs examining a range of complex interventions for people with multimorbidity. Nine studies focused on defined comorbid conditions with an emphasis on depression, diabetes and cardiovascular disease. The remaining studies focused on multimorbidity, generally in older people. In 12 studies, the predominant intervention element was a change to the organisation of care delivery, usually through case management or enhanced multidisciplinary team work. In six studies, the interventions were predominantly patient-oriented, for example, educational or self-management support-type interventions delivered directly to participants. Overall our confidence in the results regarding the effectiveness of interventions ranged from low to high certainty. There was little or no difference in clinical outcomes (based on moderate certainty evidence). Mental health outcomes improved (based on high certainty evidence) and there were modest reductions in mean depression scores for the comorbidity studies that targeted participants with depression (standardized mean difference (SMD) -2.23, 95% confidence interval (CI) -2.52 to -1.95). There was probably a small improvement in patient-reported outcomes (moderate certainty evidence) although two studies that specifically targeted functional difficulties in participants had positive effects on functional outcomes with one of these studies also reporting a reduction in mortality at four year follow-up (Int 6%, Con 13%, absolute difference 7%). The intervention may make little or no difference to health service use (low certainty evidence), may slightly improve medication adherence (low certainty evidence), probably slightly improves patient-related health behaviours (moderate certainty evidence), and probably improves provider behaviour in terms of prescribing behaviour and quality of care (moderate certainty evidence). Cost data were limited.
AUTHORS' CONCLUSIONS: This review identifies the emerging evidence to support policy for the management of people with multimorbidity and common comorbidities in primary care and community settings. There are remaining uncertainties about the effectiveness of interventions for people with multimorbidity in general due to the relatively small number of RCTs conducted in this area to date, with mixed findings overall. It is possible that the findings may change with the inclusion of large ongoing well-organised trials in future updates. The results suggest an improvement in health outcomes if interventions can be targeted at risk factors such as depression, or specific functional difficulties in people with multimorbidity.
许多慢性病患者患有不止一种慢性病,这被称为共病。“合并症”一词也被使用,但现在它指的是存在一种明确的索引疾病以及其他相关疾病,例如糖尿病和心血管疾病。当存在通常共同存在的特定疾病组合时,例如糖尿病和抑郁症,也会使用该词。虽然这不是一个新现象,但人们对其影响以及改善受影响个体结局的重要性有了更高的认识。迄今为止,该领域的研究主要集中在描述性流行病学和影响评估方面。对改善共病患者结局的干预措施的有效性探索有限。
确定旨在改善初级保健和社区环境中共病患者结局的卫生服务或以患者为导向的干预措施的有效性。共病定义为同一个体患有两种或更多种慢性病。
我们检索了截至2015年9月28日的MEDLINE、EMBASE、CINAHL和其他七个数据库。我们还检索了灰色文献,并咨询了该领域的专家以获取已完成或正在进行的研究。
两位综述作者独立筛选并选择纳入研究。我们考虑了随机对照试验(RCT)、非随机临床试验(NRCT)、前后对照研究(CBA)以及中断时间序列分析(ITS),这些研究评估了旨在改善初级保健和社区环境中共病患者结局的干预措施。共病定义为同一个体患有两种或更多种慢性病。这包括参与者可以患有任何疾病组合或患有预先指定的常见疾病组合(合并症)的研究,例如高血压和心血管疾病。对照为该环境中提供的常规护理。
两位综述作者独立从纳入研究中提取数据,评估研究质量,并使用GRADE方法判断证据的确定性。我们在可能的情况下对结果进行荟萃分析,并对其余结果进行叙述性综合。我们以“结果总结”表和表格形式呈现结果,以显示所有结局类型的效应大小。
我们确定了18项RCT,这些研究针对共病患者检验了一系列复杂干预措施。9项研究聚焦于特定的合并症,重点是抑郁症、糖尿病和心血管疾病。其余研究聚焦于共病,通常是在老年人中。在12项研究中,主要的干预要素是护理提供组织的改变,通常是通过病例管理或加强多学科团队协作。在6项研究中,干预措施主要是以患者为导向的,例如直接向参与者提供教育或自我管理支持类型的干预措施。总体而言,我们对干预措施有效性结果的信心从低到高不等。临床结局几乎没有差异(基于中等确定性证据)。心理健康结局有所改善(基于高确定性证据),针对患有抑郁症的参与者的合并症研究中,平均抑郁评分有适度降低(标准化平均差(SMD)-2.23,95%置信区间(CI)-2.52至-1.95)。患者报告的结局可能有小幅改善(中等确定性证据),尽管两项专门针对参与者功能困难的研究对功能结局有积极影响,其中一项研究还报告在四年随访时死亡率降低(干预组6%,对照组13%,绝对差异7%)。干预措施可能对卫生服务利用几乎没有影响(低确定性证据),可能会略微提高药物依从性(低确定性证据),可能会略微改善与患者相关的健康行为(中等确定性证据),并且可能会改善提供者在处方行为和护理质量方面的行为(中等确定性证据)。成本数据有限。
本综述确定了新出现的证据以支持初级保健和社区环境中共病及常见合并症患者管理的政策。由于该领域迄今为止进行的RCT数量相对较少,总体结果不一,因此对于共病患者干预措施的有效性仍存在不确定性。随着未来更新中纳入大型、组织良好的正在进行的试验,结果可能会发生变化。结果表明,如果干预措施能够针对抑郁症等风险因素或共病患者的特定功能困难,健康结局可能会得到改善。